Mark P. Hamilton
Impact in
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer Genomics and Diagnostics 16
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 2
- Oncology 22
- CAR-T cell therapy research 22
- Co-authors
- Sean Eric McGuire (9 shared papers)Sean Michael Hartig (8 shared papers)Philipp E. Scherer (3 shared papers)Jayoung Kim (1 shared paper)Nils Halberg (1 shared paper)Katherine Luby‐Phelps (1 shared paper)Todd Schraw (1 shared paper)Zhao V. Wang (1 shared paper)
- Journals
- Nature Communications (12 papers)Transplantation and Cellular Therapy (8 papers)Nature (7 papers)Blood (5 papers)Nature Genetics (5 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Mark P. Hamilton
64 papers receiving 10.9k citations
Mark P. Hamilton's Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 2.6k
- Oncology 1.1k
- Molecular Biology 1.6k
- Genetics 161
- Genetics 472
Countries citing papers authored by Mark P. Hamilton
This map shows the geographic impact of Mark P. Hamilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Hamilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Hamilton more than expected).
Fields of papers citing papers by Mark P. Hamilton
This network shows the impact of papers produced by Mark P. Hamilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Hamilton. The network helps show where Mark P. Hamilton may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark P. Hamilton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2401 |
| 2 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2169 |
| 3 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 730 |
| 4 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 564 |
| 5 | Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Hit paper breakdown → | 2020 | 489 |
| 6 | Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Hit paper breakdown → | 2020 | 428 |
| 7 | Comprehensive molecular characterization of mitochondrial genomes in human cancers Hit paper breakdown → | 2020 | 319 |
| 8 | Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition Hit paper breakdown → | 2020 | 315 |
| 9 | Genomic basis for RNA alterations in cancer Hit paper breakdown → | 2020 | 310 |
| 10 | The landscape of viral associations in human cancers Hit paper breakdown → | 2020 | 293 |
| 11 | 2022 | 201 | |
| 12 | 2020 | 190 | |
| 13 | 2009 | 180 | |
| 14 | 2020 | 167 | |
| 15 | 2020 | 161 | |
| 16 | 2020 | 153 | |
| 17 | 2016 | 148 | |
| 18 | Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy Hit paper breakdown → | 2024 | 147 |
| 19 | 2018 | 144 | |
| 20 | 2020 | 109 |
About Mark P. Hamilton
Mark P. Hamilton is a scholar working on Cancer Research, Oncology, Physiology, Epidemiology and Ophthalmology, having authored 69 papers that have together received 11.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (22 papers), Cancer Genomics and Diagnostics (16 papers), MicroRNA in disease regulation (5 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers), Adipose Tissue and Metabolism (3 papers), Mosquito-borne diseases and control (2 papers), Cancer-related molecular mechanisms research (2 papers) and Ocular Oncology and Treatments (1 paper). The work is most often cited by research in Cancer Research (2.6k citations), Oncology (1.1k citations), Molecular Biology (1.6k citations), Genetics (161 citations) and Genetics (472 citations). Mark P. Hamilton has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Sean Eric McGuire, Sean Michael Hartig, Philipp E. Scherer, Jayoung Kim, Nils Halberg, Katherine Luby‐Phelps, Todd Schraw, Zhao V. Wang, Cristian Coarfa and Kimal Rajapakshe. Their work appears in journals such as Nature Communications, Transplantation and Cellular Therapy, Nature, Blood and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.